Biomerica Announces Preliminary Second Quarter Revenue Increase of Approximately 238%, to Approximately $4.6 Million

NEXT STORY
Fortress Biotech Announces Initiation of Phase 2 Clinical Trial of Triplex for Adults Co-Infected with HIV and CMV
PREV STORY
InveniAI and Kyowa Kirin Expand AI-Driven Partnership to a Multi-Year Strategic Collaboration for the Discovery of Novel Targets and Treatments Across Therapeutic Areas
Subscribe now to PM360
Get in touch with PM360 Experts On Call

Experts on Call

Ads

You May Also Like

Colon Cancer Foundation Marks Colorectal Cancer Awareness Month with Virtual Concert for a Cause

author_avatar
NASDAQ Market News

BriaCell to Participate at the H.C. Wainwright 23rd Annual Global Investment Conference September 13-15, 2021

author_avatar
NASDAQ Market News

Intellia Therapeutics Announces Third Quarter 2018 Financial Results and Corporate Developments

Enhanced in vivo CRISPR/Cas9 cargo components have led to substantially increased liver editing and ...

author_avatar
NASDAQ Market News